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Case report 
A 59-year-old man presented with a 7-month history of  
left shoulder pain. The pain became increasingly severe, 
and he was admitted as an emergency under the care of  
the orthopedic surgeons for assessment and treatment. He 
was a nonsmoker and had no significant previous medical 
history. 
A chest x-ray performed on admission, along with plain 
films of  his left humerus (Fig. 1), showed near absence of  
much of  the left scapula. There were scattered lucent 
changes in other bones, in particular the left humerus.
Laboratory investigations revealed mild anemia, with 
hemoglobin of  11.1 g/dl. There was also a moderate renal 
impairment, and serum creatinine on admission was 279 
µmol per liter. 
A CT scan of  the thorax, abdomen, and pelvis con-
firmed the presence of  widespread lytic bony lesions, with a 
large soft-tissue mass centered around the left scapula (Fig. 
2). An isotope bone scan demonstrated absence uptake in 
the left scapula, but note was made of  a striking increased 
uptake by the stomach. There was also apparent increased 
uptake of  tracer in the nasal mucosa, as well as low-grade 
uptake in the lung parenchyma (Fig. 3).
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A 59-year-old man presented with a 7-month history of  increasing left shoulder pain. The initial plain 
films showed near absence of  the left scapula and scattered lucent changes in the left humerus. A CT 
scan confirmed the presence of  widespread lytic bony lesions, with a large soft-tissue mass centered 
around the left scapula. An isotope bone scan demonstrated marked uptake of  MDP in the stomach and 
nasal mucosa. Further laboratory investigations revealed marked hypercalcemia and the presence of  
Bence-Jones protein in the urine. An ultrasound-guided biopsy of  the soft-tissue mass confirmed the di-
agnosis of  multiple myeloma.
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Figure 1. 59-year-old male with myeloma. Plain films of the 
chest and left humerus. The left scapula is almost entirely 
destroyed. Only a small amount of the acromion remains. 
The film of the left humerus demonstrates permeative bone 
loss throughout. A well-defined, punched-out lytic lesion is 
seen in relation to the midshaft of the left humerus.
Hypercalcemia was suspected because of  the marked 
gastric uptake, and the clinical team was advised to check 
the serum calcium level; it was found to be 4.26 mmol per 
liter (normal range, 2.15 to 2.60). Appropriate emergency 
treatment for the marked hypercalcemia was instituted. 
Subsequent urine analysis demonstrated positive Bence 
Jones protein, and an ultrasound-guided biopsy of  the soft-
tissue mass arising from the left scapula confirmed the di-
agnosis of  myeloma.
Discussion
Gastric and soft-tissue uptake of  MDP has been de-
scribed in a number of  malignant and nonmalignant dis-
eases in the context of  hypercalcemia, including bronchial 
carcinoma (1), vitamin D intoxication (2), sarcoidosis (3), 
and (as in this case) myeloma (4, 5). In one case, gastric 
uptake was shown to improve following reversal of  hyper-
calcemia in a patient with primary hyperparathyroidism (6).  
Kanoh et al performed gastric biopsies in a patient with 
myeloma that demonstrated amyloid deposits, and it was 
hypothesized that this was the cause of  the observed activ-
ity (5). Pulmonary uptake of  MDP has also been described 
in hypercalcemia (7), and we take this to be the cause in this 
case. 
Isotope bone scanning with MDP is not routinely rec-
ommended for the detection of  skeletal involvement in 
myeloma, as the osteolytic lesions typically induce little or 
no osteoblastic response (8). However, some literature sup-
ports the use of  Tc-99m Hexakis (2-methoxy-2-
methylpropylisonitrile) (MIBI) in assessment, staging the 
prediction of  prognosis in myeloma (9). More recently, 
skeletal involvement with myeloma has also been reported 
with 18F-fluorodeoxyglucose positron-emission tomogra-
phy, as well as positron-emission tomography with 11C 
choline (10).
In our case, there was also marked nasal uptake of  MDP. 
After nasendoscopy, the patient's nasal mucosa was found 
to be entirely normal. Increased uptake of  MDP in the 
paranasal sinuses may be posttraumatic or related to in-
flammatory or infective pathology (11, 12). In our patient, 
there was no history of  trauma or any other clinical evi-
dence of  inflammatory change in the nasal cavity or naso-
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Figure 2. 59-year-old male with myeloma. Contrast-
enhanced CT scan of the thorax. The left scapula was al-
most entirely missing. It was replaced by a large, homoge-
neous soft-tissue mass that was biopsied, confirming the 
diagnosis of myeloma.
Figure 3. Isotope bone scan. Planar whole-body images 
obtained three hours following administration of 500 MBq 
of Tc-99m methylene diphosphonate (MDP). The striking 
finding was that of marked increased uptake by the stom-
ach. Initially, the possibility of “free pertechnetate” was 
raised; however, none of the other patients scanned on the 
same day had any similar findings, and there was no sali-
vary or thyroid uptake. This was therefore genuine gastric 
uptake of MDP. There was also increased activity arising 
from the nasal mucosa, as well as low-grade uptake in the 
lung parenchyma. (Uptake in the right 5th and 9th ribs pos-
teriorly was related to minimally displaced fractures).
pharynx. It is therefore possible that the nasal uptake was 
also related to the patient's marked hypercalcemia.
Prominent gastric uptake of  MDP should therefore alert 
the reporting radiologist or physician to the possibility of  
hypercalcemia. 
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